Clinical trial
Daily Topical Rapamycin Therapy for the Treatment of Vitiligo
NCT05342519 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Daily Topical Rapamycin Therapy for the Treatment of Vitiligo
- Lead sponsor
- Medical University of South Carolina
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- July 28, 2022
- Completion date
- December 1, 2027
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.